We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
Cap. Flow
+$802M
Cap. Flow %
0.75%
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$78.7M
2
XYZ
Block Inc
XYZ
+$49.3M
3
V icon
Visa
V
+$46.1M
4
AAPL icon
Apple
AAPL
+$45.4M
5
DASH icon
DoorDash
DASH
+$45.1M

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Financials 14.43%
3 Healthcare 10.97%
4 Consumer Discretionary 10.82%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XERS icon
2101
Xeris Biopharma Holdings
XERS
$1.44B
$1.06M ﹤0.01%
192,281
+11,317
+6% +$45.7K
MBWM icon
2102
Mercantile Bank Corp
MBWM
$1.04B
$1.05M ﹤0.01%
24,272
-1,147
-5% -$53.2K
WLFC icon
2103
Willis Lease Finance
WLFC
$1.21B
$1.05M ﹤0.01%
20,016
-1,203
-6% -$76.5K
TXG icon
2104
10x Genomics
TXG
$7.55B
$1.05M ﹤0.01%
120,490
+12,374
+11% +$156K
TAK icon
2105
Takeda Pharmaceutical
TAK
$56B
$1.05M ﹤0.01%
70,632
-3,905
-5% -$54.7K
FLNG icon
2106
FLEX LNG
FLNG
$1.65B
$1.05M ﹤0.01%
45,632
+141
+0.3% +$3.37K
WOLF icon
2107
Wolfspeed
WOLF
$1.55B
$1.05M ﹤0.01%
342,505
+33,361
+11% +$195K
AVXL icon
2108
Anavex Life Sciences
AVXL
$316M
$1.04M ﹤0.01%
120,993
-2,706
-2% -$25.6K
ELVN icon
2109
Enliven Therapeutics
ELVN
$4.33B
$1.03M ﹤0.01%
52,502
+2,466
+5% +$53.1K
VTS icon
2110
Vitesse Energy
VTS
$680M
$1.03M ﹤0.01%
41,966
+37
+0.1% +$947
UDMY
2111
DELISTED
Udemy
UDMY
$1.03M ﹤0.01%
132,289
+1,613
+1% +$13.7K
FG icon
2112
F&G Annuities & Life
FG
$3.58B
$1.02M ﹤0.01%
28,420
-1,213
-4% -$50.9K
QFIN icon
2113
Qfin Holdings
QFIN
$1.58B
$1.02M ﹤0.01%
22,798
-2,190
-9% -$90.7K
BUD icon
2114
AB InBev
BUD
$163B
$1.02M ﹤0.01%
16,616
-178
-1% -$9.74K
AMTB icon
2115
Amerant Bancorp
AMTB
$1.12B
$1.02M ﹤0.01%
49,361
-4,448
-8% -$98.6K
HTHT icon
2116
Huazhu Hotels Group
HTHT
$13.2B
$1.02M ﹤0.01%
27,443
-7,245
-21% -$251K
MBIN icon
2117
Merchants Bancorp
MBIN
$2.48B
$1.01M ﹤0.01%
27,288
-1,465
-5% -$57.8K
EOLS icon
2118
Evolus
EOLS
$498M
$1M ﹤0.01%
83,436
+3,287
+4% +$43K
BV icon
2119
BrightView Holdings
BV
$1.06B
$1M ﹤0.01%
78,153
-4,367
-5% -$62.5K
CENT icon
2120
Central Garden & Pet Co
CENT
$2.73B
$1M ﹤0.01%
27,304
-1,748
-6% -$64K
HBNC icon
2121
Horizon Bancorp
HBNC
$1.03B
$1,000K ﹤0.01%
66,308
-3,592
-5% -$58.3K
WULF icon
2122
TeraWulf
WULF
$8.17B
$1,000K ﹤0.01%
366,217
+19,216
+6% +$85.6K
BXC icon
2123
BlueLinx
BXC
$714M
$997K ﹤0.01%
13,293
-462
-3% -$42.9K
AVDL
2124
DELISTED
Avadel Pharmaceuticals
AVDL
$995K ﹤0.01%
127,027
+2,890
+2% +$24.2K
PL icon
2125
Planet Labs
PL
$8.32B
$994K ﹤0.01%
293,950
+6,692
+2% +$31.3K

Similar funds

RhumbLine Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
  • RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
  • RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
  • RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
  • RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
  • RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
  • RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.